Across TCGA pan-cancer cohorts, ATP5MGP4 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ATP5MGP4’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ATP5MGP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP5MGP4 is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

COAD, PRAD, and THCA are the cancer types where ATP5MGP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP5MGP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.390	<.001	5	view →
PRAD	All	All	+0.064	.047	2	view →
THCA	Male	III,IV	−0.221	.049	1	view →
KIRC	All	All	−0.014	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: ATP5MGP4 RNA expression & survival · all ATP5MGP4 data types